TITLE

Perioperative perfusion strategies for optimal fluid management in liver transplant recipients with renal insufficiency

AUTHOR(S)
Blackwell, M M; Chavin, K D; Sistino, J J
PUB. DATE
January 2003
SOURCE
Perfusion;Jan2003, Vol. 18 Issue 1, p55
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Renal Insufficiency (RI) is a common finding in patients suffering from end-stage liver disease. The causes of RI are reported to be multifactorial and the degree of RI can range from early functional impairment to hepatorenal syndrome (HRS). The process of liver transplantation is highly likely to exacerbate the symptoms and sequelae of renal dysfunction. RI continues to be a cause of morbidity and mortality in the intraoperative and postoperative periods. With careful evaluation and monitoring in addition to appropriate intervention, a uniformly good outcome may be possible even for these most complicated patients. This paper will describe successful perfusion interventions carried out during the three phases of liver transplantation: pre-anhepatic, anhepatic and reperfusion at our institution for a three-year period. Intraoperative plasmapheresis (n = 3), continuous veno-venous hemofiltration (CVVH) (n = 7), intraoperative dialysis (n = 8), and intraoperative dialysis with fluid removal (n = 3) techniques will be presented for review.
ACCESSION #
9459297

 

Related Articles

  • Influence of a low sodium diet on the renal response to amino acid infusions in humans. Ruilope, Luis M.; Rodicio, Jose; Robles, Rafael Garcia; Sancho, Jose; Miranda, Blanca; Granger, Joey P.; Romero, J. Carlos // Kidney International;Apr1987, Vol. 31 Issue 4, p992 

    In experimental animals, a high protein diet has been shown to accelerate end-stage renal disease by inducing glomerular hyperperfusion. In this study, we found that intravenous administration of amino acid, used as one component of parenteral nutrition, to normal volunteers resulted in a...

  • What is new in arterial stiffness clinical research? Gusbeth-Tatomir, Paul; Covic, Adrian // Maedica - a Journal of Clinical Medicine;2009, Vol. 4 Issue 1, p12 

    Arterial stiffness has been recognized recently as a powerful predictor of cardiovascular (CV) and general mortality both in the general population, in high-risk non-renal patients, and in chronic kidney disease (CKD) patients. Stiffened arteries have significant clinical consequences on cardiac...

  • Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. Thomas Ming Swi Chang // Kidney International Supplement;Dec1976, Issue 7, p305 

    Presents a study which sought to review the use of activated charcoal (ACAC) microcapsule hemoperfusion for the treatment of patients with chronic renal failure, acute intoxication and liver failure. Widespread and successful use of hemodialysis for the treatment of patients with chronic renal...

  • Chronic kidney disease and risk for coronary events: Value of myocardial perfusion imaging. Beller, George A. // Journal of Nuclear Cardiology;Sep2010, Vol. 17 Issue 5, p759 

    The article explores the value of stress myocardial perfusion imaging (MPI) in the identification of chronic kidney disease (CKD) patients who have increased risk of cardiac death. Among the traditional risk factors associated with coronary artery disease (CAD) and cardiovascular events in CKD...

  • Trying to meet the demands in organ transplantation. Nguan, Christopher // Canadian Urological Association Journal;Dec2012, Vol. 6 Issue 6, p453 

    The author discusses the low availability of donars for organ transplantations to treat kidney failure. Topics discussed include utilizing kidneys from donors undergoing neurological determination of death (NDD), organs form patients who undergo removal of cardiocirculatory support, Donation...

  • Erythropoietin stops chronic diffuse transfusion-dependent gastrointestinal bleeding. Zaharia-Czeizler, Veronica; Zaharia-Czeizler, V // Annals of Internal Medicine;11/20/2001, Vol. 135 Issue 10, p933 

    Examines the benefits of erythropoietin in anemic patient with chronic renal failure. Decline in the bleeding time in uremic patients; Increase in the platelet count; Decrease in protein C, protein S and antithrombin III levels.

  • CKDu Ravages the Salvadoran Countryside. Gorry, Conner // MEDICC Review;Apr2014, Vol. 16 Issue 2, p5 

    This article focuses on the prevalence of chronic kidney disease (CKD) of unknown etiology among poor farmworkers in El Salvador. Topics discussed include the extent and nature of the problem, the risk factors for CKD, and the response of the Ministry of Health and the Salvadoran government to...

  • HOOFING IT HEALTHY FOR KIDNEY PATIENTS' HEARTS.  // Canadian Nurse;May2014, Vol. 110 Issue 4, p8 

    The article discusses a study of 40 patients with chronic kidney disease where immune cell activation and markers of systematic inflammation were reduced among patients who added a 30-minute walk to their daily routine.

  • Incidence of RCN in Chronic Renal Failure Unaffected by HD.  // Kidney;Sep/Oct98, Vol. 7 Issue 5, p208 

    Discusses the abstract of a study entitled 'Effect of haemodialysis after contrast medium administration in patients with renal insufficiency,' by T. Lehnert, E. Keller, K. Gondolf and others, published in the 1998 issue of 'Nephrology, Dialysis, Transplantation.'

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics